Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? (Q35228788)

7 August 2017

1 reference

title

Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? (English)

1 reference

7 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

5 December 2023

M. A. Giembycz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318047

5 December 2023

language of work or name

English

0 references

publication date

1 May 1992

1 reference

7 August 2017

28 May 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1318047

full work available at URL

5 December 2023

https://api.elsevier.com/content/article/PII:000629529290160K?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

https://api.elsevier.com/content/article/PII:000629529290160K?httpAccept=text/plain

5 December 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

5 December 2023

published in

Biochemical Pharmacology

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

2041-2051

1 reference

Prevalence of asthma and hay fever in England and Wales

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Has the management of asthma improved?

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Lung inflammation, its significance for asthma therapy

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

The pathology of asthma, with special reference to changes in the bronchial mucosa

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Damage of the airway epithelium and bronchial reactivity in patients with asthma

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Cellular events in the bronchi in mild asthma and after bronchial provocation

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Regular inhaled beta-agonist treatment in bronchial asthma.

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Multiple isozymes of cyclic nucleotide phosphodiesterase

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytes

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Regulation of interleukin 2 synthesis by cAMP in human T cells

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Human alveolar macrophage activation: inhibition by forskolin but not beta-adrenoceptor stimulation or phosphodiesterase inhibition

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Cyclic-GMP-dependent refilling of calcium stores in macrophages

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai.

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Cardiovascular effect and stimulus-dependent inhibition of superoxide generation from human neutrophils by tibenelast, 5,6-diethoxybenzo(b)thiophene-2-carboxylic acid, sodium salt (LY186655).

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Zardaverine as a selective inhibitor of phosphodiesterase isozymes

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Influence of cyclic nucleotides and a phosphodiesterase inhibitor on in vitro human blood neutrophil chemotaxis

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N2,2'-O-dibutyryl guanosine 3':5'-cyclic monophosphate.

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Zardaverine: a cyclic AMP specific PDE III/IV inhibitor

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

Phospholipid and arachidonic acid metabolism in zymosan-stimulated human monocytes: modulation by cAMP

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function

5 December 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(92)90160-K

5 December 2023

Identifiers

DOI

1 reference

7 August 2017

1 reference